DMKPQ — DMK Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$6.66m
- $4.76m
Brief: Adamis Pharmaceuticals Reports Full Year 2022 Financial Results And Provides Corporate Update
Brief: Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
Brief: Adamis Pharmaceuticals Gets Notice Of Not Satisfy Certain Requirement From Nasdaq
Brief: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Corporate Update
Brief: Adamis Announces Review Of Strategic Alternatives
U.S. STOCKS ON THE MOVE-Freyr Battery, General Mills, Coty, ShiftPixy
U.S. STOCKS ON THE MOVE-ShiftPixy, Sesen Bio, U.S. airlines
U.S. STOCKS ON THE MOVE-Stitch Fix, Adamis Pharmaceuticals, Coty, Micron
Adamis Pharma falls to record low after COVID-19 drug trial misses main goal
Brief: Adamis Provides Update On Phase 2/3 Trial Of Tempol In COVID-19 Positive High-Risk Subjects
Brief: Adamis Provides An Enrollment Update On The Phase 2/3 Study Of Tempol In COVID-19 Positive High-Risk Subjects
Brief: Adamis Pharmaceuticals Files For Mixed Shelf Of Up To $300 Mln
Adamis Pharmaceuticals Corp reports results for the quarter ended in June - Earnings Summary
Brief: Adamis Pharmaceuticals Corp QTRLY Loss Per Share $0.06
Adamis Pharmaceuticals Corp expected to post a loss of 4 cents a share - Earnings Preview
Brief: ISS Recommends Adamis Pharmaceuticals' Stockholders Vote For Critical Proposals At Upcoming Annual Meeting
Brief: Adamis Pharmaceuticals Provides Update On Clinical Study Assessing Tempol For Treatment Of Covid-19
U.S. STOCKS ON THE MOVE-Lithium stocks, 3M, TG Therapeutics
U.S. STOCKS ON THE MOVE-Salesforce, Enochian BioSciences, Spark Networks